Paul L. Weiden
BioPharma Consulting?Services LLC
United States of America
Dr. Weiden worked for biotechnology firms involved in developing chemotherapeutic agents and cellular immunotherapy of cancer. During the previous 20 years, Dr. Weiden was a member of the Section of Hematology-Oncology at Virginia Mason Medical Center in Seattle, WA. In addition to a full clinical practice in this tertiary medical center, Dr. Weiden served as Principal Investigator of the Community Clinical Oncology Program (CCOP) where he gained experience in cooperative group trials and as the Principal Investigator responsible for the design and conduct of phase 1/2 trials involving radiolabeled monoclonal antibodies. Dr. Weiden also served as Medical Director of the Cancer Clinical Research Unit and as a member of the Ethics Committee and the Research Advisory Committee, each of which provided unique exposure to different aspects of clinical research. From 1971 to 1980, Dr. Weiden was a member of the Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, where he was involved in studies of stem cell transplantation and tumor immunotherapy. Dr. Weiden's training includes Harvard College and Medical School and the National Cancer Institute, Bethesda, Maryland.
His research interests includes clinical and preclinical aspects of oncology,hematology,radiolabelled monoclonal antibody therapy and stem cell transplantation.